Correlation Between Defence Therapeutics and Protagenic Therapeutics
Can any of the company-specific risk be diversified away by investing in both Defence Therapeutics and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Defence Therapeutics and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Defence Therapeutics and Protagenic Therapeutics, you can compare the effects of market volatilities on Defence Therapeutics and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Defence Therapeutics with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Defence Therapeutics and Protagenic Therapeutics.
Diversification Opportunities for Defence Therapeutics and Protagenic Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Defence and Protagenic is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Defence Therapeutics and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Defence Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Defence Therapeutics are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Defence Therapeutics i.e., Defence Therapeutics and Protagenic Therapeutics go up and down completely randomly.
Pair Corralation between Defence Therapeutics and Protagenic Therapeutics
Assuming the 90 days horizon Defence Therapeutics is expected to generate 0.08 times more return on investment than Protagenic Therapeutics. However, Defence Therapeutics is 13.18 times less risky than Protagenic Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 41.00 in Defence Therapeutics on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Defence Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Defence Therapeutics vs. Protagenic Therapeutics
Performance |
| Timeline |
| Defence Therapeutics |
| Protagenic Therapeutics |
Defence Therapeutics and Protagenic Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Defence Therapeutics and Protagenic Therapeutics
The main advantage of trading using opposite Defence Therapeutics and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Defence Therapeutics position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.| Defence Therapeutics vs. Sino Biopharmaceutical Ltd | Defence Therapeutics vs. Institute of Biomedical | Defence Therapeutics vs. Aileron Therapeutics | Defence Therapeutics vs. Enlivex Therapeutics |
| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |